Comprehensive analysis of Genomic Medicine Market has been published by Absolute Markets Insights to understand the extensive market scenario of Genomic Medicine industries. The report uses a variety of powerful qualitative and quantitative analysis techniques to accurately locate data. Moreover, the report likewise centers around the most recent industry-driving advancements to assist with directing industry improvement.
Key Players Operating in Global Genomic Medicine Market: Abomics Ltd, Cerecor, Inc. (Aevi Genomic Medicine, Inc.), Congenica Ltd, DEEP GENOMICS, Editas Medicine, EUROESPES, Genome Medical, Inc., Helix OpCo LLC, Parexel International Corporation, Sangamo Therapeutics, and uniQure N.V
Please click the link below to get a full report: https://www.absolutemarketsinsights.com/reports/Genomic-Medicine-Market-2019-2027-518
In terms of revenue, the global genomic medicine market was valued at US$ 4,840.0 Bn in 2020 and is expected to reach US$ 11,785.5 Bn by 2030 growing at a CAGR of +10.5% over the forecast period. The study analyzes the market in terms of revenue across all the major regions, which has been further bifurcated into countries.
Based on component, the genomic medicine market has been bifurcated into gene medicine and platforms & services. Among all, platforms & services is expected to witness the favorable market growth during the forecast period. Companies are developing platforms to ease the diagnosis for doctors as wells as for patients. For example, Genome Medical, Inc. has developed a platform called telehealth in which individuals and healthcare providers can connect with genetic experts with the assistance of the cloud-based platform, telehealth. With the help of telehealth, individuals and healthcare providers can receive counseling on the health issues they might face as well as they can gain advice on how to implement a healthier lifestyle based on their genetic makeup.
Therapeutic Area Outlook:
The genomic medicine market is gaining momentum with its growing applications in various therapeutic areas such as oncology, cardiology, pediatrics, endocrinology, respiratory medicine, rare genetic disorders, and infectious diseases, among others. The oncology segment will hold the major share in the genomic medicine market owing to increasing rate of cancer cases across the world. For example, according to the National Cancer Institute (NCI), in the U.S., there has been 439.2 per 100,000 men and women cancer cases registered per year between 2011 and 2015. Out of this, the number of deaths from cancer is 163.5 per 100,000 men and women registered per year between 2011 and 2015.
Global Genomic Medicine Market: Key Segmentation
- Gene Medicine
- Platforms & Services
- Respiratory Medicine
- Rare Genetic Disorders
- Infectious Diseases
By End Users
- Hospitals & Clinics
- Academic Institutes & Research Centers
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: firstname.lastname@example.org
Phone: IN +91-7400-24-24-24, US +1-510-420-1213